Navigation Links
ActCel Hemostatic Gauze

ProductsActCel Hemostatic Gauze
Company ActSys Medical, Inc.
Item ActCel Hemostatic Gauze
Features ActCel stops bleeding quickly and effectively by:
  • Adhering - ActCel hemostatic gauze adheres to the bleeding surface, physically blocking and sealing off the damaged blood vessels.
  • Expanding - Once in contact with the blood, ActCel expands to create direct pressure and helps stop bleeding.
  • Transforming - ActCel transforms into a collagen-like gel that increases platelet aggregation and stabilizes clot formation.
  • Dissolving - ActCel is water-soluble and is easily rinsed away with sterile water, saline or hydrogen peroxide. Once ActCel has helped form a clot, it will dissolve into a glucose saline gel in 1-2 weeks.
Description ActCel Hemostatic Gauze is a collagen-like natural substance created from chemically treated cellulose. It is an effective, patented, hemostatic agent registered with the FDA to help control bleeding from open wounds and in body cavities. The material contains no chemical additives, thrombin or collagen and is hypoallergenic. When it comes in contact with blood, it expands to 3-4 times its original size and converts to a gel that dissolves into glucose and saline over a 1-2 week period. Because of its purity and the fact that it simply degrades to these end products, ActCel does not cause delayed healing as do other hemostatic material that may have similar appearance.

Research shows that ActCel effectively cuts down on clotting time, helps stabilize new clots by accelerating the formation of fibrin cross-linkages and increases whole blood viscosity, thus promoting the aggregation of red blood cells.

ActCel has been and continues to be a successful stop-bleeding product in the dental, OB/GYN, EMS, Veterinary and Athletic industries.

Some benefits of ActCel include:

  • Quick clotting time
  • No additives to delay healing
  • Breaks down into saline and glucose
  • Sterile and bacteriostatic
  • All Natural
  • Hypo-allergenic
  • Cost effective
  • No reported side effects
Info ActSys Medical, Inc.
Customer Service: (800) 808-9094
Web site: http://www.actcel.com

Related medicine products :

1. Hartman Hemostatic Mosquito Straight forceps
2. Hartman Hemostatic Mosquito Curved forceps
3. Wet-Field Hemostatic Eraser Bipolar Tip (18 gauge Straight w/45 bevel tip)
4. Wet-Field Hemostatic Eraser Bipolar Tip (20 gauge Straight, Long Shaft)
5. Wet-Field Hemostatic Eraser Bipolar Tip (20 gauge Curved 135)
6. Wet-Field Hemostatic Eraser Bipolar Tip (20 gauge Curved 150)
7. Wet-Field Hemostatic Eraser Bipolar Tip
8. Wet-Field Hemostatic Eraser Bipolar Tip (20-23 gauge Tapered/Blunt Point, Curved 150)
9. Wet-Field Hemostatic Eraser Bipolar Tip (20-23 gauge Tapered/Blunt Point, Straight)
10. Wet-Field Hemostatic Eraser Bipolar Tip (20-23 gauge Tapered/Blunt Point, Curved 90)
11. Wet-Field Hemostatic Eraser Bipolar Tip (20-23 gauge Tapered/Blunt Point, Curved 135)
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products:
(Date:7/25/2008)... WASHINGTON, July 25 /PRNewswire/ -- Klafter &...t ArthroCare Corporation ("ArthroCare" or the,"Com...s in the U.S. District,Court for the Western Distr...who purchased the common stock ArthroCare from Jan...tock Purchaser Class Period") and all,persons or e...
(Date:7/25/2008)... PLEASANTON, Calif., July 25 /PRNewswire-First...orld leader in device-based mechanical,circulatory...iling hearts,today announced that it will report ...irst six months of fiscal 2008 on Thursday, July 3...scuss its financial,results and operating activiti...
(Date:7/25/2008)..., OAK BROOK, Ill. July 25, 2008 The American S...ssued guidelines on the role of endoscopy in the b... obesity in the United States and the success in s...the number of weight-loss surgeries performed in t...he guidelines discuss endoscopy in the preoperativ...
(Date:7/25/2008)... SullivanCotter Releases Results of Fourth Annu... Survey, DETROIT, July 25 /PRNewswire/ -- S... its fourth annual survey of physician on-call pay...ay Survey Report. The survey report,with data fro...s physician,on-call pay practices and rates paid f...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3
...igh of relief for researchers at the Massachusetts...loped two robotic devices that mimic the human ank...s. Dr. Hugh Herr, Assistant Professor and Directo...e institute, has been quoted by Discovery News as ...
...edly wetter than earlier believed, a new study car...stems (RSS) has said. According to the satellite...colleagues, global temperatures have risen, but pr...ept pace. The findings also cast doubt on the abi...
...versity Comprehensive Cancer Center have discovere...more vulnerable to chronic lymphocytic leukaemia (...n greatly reduces the gene's protective activity. ... occurs later that turns the gene off altogether, ...
...day expressed concerns that the number of babies d...in Australia. The number of children dying from Su...9 in 2004 to 87 in 2005, SIDS and Kids Western Aus...le said. Doyle said education programs about safe...
Other Medicine News:Health News:Now, Natural Looking, Energy Efficient Robotic Ankles for Amputees 2Health News:World may Get Much Wetter With Global Warming Than Believed 2Health News:Gene Mutation That Increases the Risk of Chronic Lymphocytic Leukaemia Found 2
(Date:7/24/2008)... NEW ORLEANS, July 24 /PRNewswire-USNewswire/...eloped for mental illnesses, according to a new,re...cused on the,devastating effects that mental illne.... Nationwide, mental illness affects nearly 60 mil...rmaceutical Research and Manufacturers,of America ...
(Date:7/24/2008)... SOPHIA ANTIPOLIS, France, July 24 /PRNewswir...oday announced the top-line results from the 52-we...following the completion of,the 301 phase 3 study ...d,safety findings and efficacy was maintained for ... the patients, global assessment scale. In,additio...
(Date:7/23/2008)... BOSTON, July 23 /- FluoroPharma... imaging agents for the Positron Emission Tomograp...s for BFPET, its novel,Fluorine-18 labeled tracer ...harma,s second cardiovascular product to complete ...ging agent, designed to assess the blood flow in t...
(Date:7/22/2008)... BRISBANE, Australia, July 22 /PRNewswire-Fir...ded late yesterday, the Board of Progen,Pharmaceut...nced that it,had discontinued the PI-88 phase 3 st...c direction to develop its existing portfolio of c...uire additional compounds and,opportunities throug...
Breaking Medicine Technology:More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 1Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 2Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 3Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 4Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 5Human safety prosperity depend on better ocean observing system 3A Scientists 1319 1Human safety prosperity depend on better ocean observing system 3A Scientists 1319 2Human safety prosperity depend on better ocean observing system 3A Scientists 1319 3Human safety prosperity depend on better ocean observing system 3A Scientists 1319 4Human safety prosperity depend on better ocean observing system 3A Scientists 1319 5Human safety prosperity depend on better ocean observing system 3A Scientists 1319 6Human safety prosperity depend on better ocean observing system 3A Scientists 1319 7Human safety prosperity depend on better ocean observing system 3A Scientists 1319 8Age burden divorce and heavy tea consumption are significant risk factors for erosive esophagitis 6850 1Dr Dello Russo Introduces the New EYE Q Lasik 901 1